Navigation Links
XCalibur EMG System

ProductsXCalibur EMG System
Company Xltek
Item XCalibur EMG System
Features XCalibur's comprehensive software tools and convenient hardware design make performing recruited and stimulated single fiber studies easy. And evoked potential testing is handled just as simply. In addition, audio and video clips of needle EMG studies can be stored and saved for reference and/or exported to various formats for emailing. Lastly, you'll also pleasantly discover that our software is intuitive as well as functional.
Description Since 1995, the XLTEK NeuroMax has led the portable EMG market. NeuroMax owners have benefited from a decade of reliable, accurate testing anywhere, anytime. XCalibur expands on that legacy of innovation and experience to satisfy the needs of leading diagnostic and teaching centers. High-end EMG diagnosis and instruction demand recordings with the maximum fidelity and the lowest noise possible. See for yourself XLTEK's amplifier and stimulator designs deliver superb tracings of both peripheral surface and fine-gauge invasive recordings. To address the exacting requirements of both research investigators and clinical practitioners, XLTEK created XCalibur an exciting new electrodiagnostic platform. XCalibur satisfies the demands of electromyographers in tertiary care as well as teaching institutions. Choose XCalibur not only to meet your present needs but to simplify your future wants.
Info Xltek
Customer Service: (800) 387 7516
Web site: http://www.xltek.com

Related medicine products :

1. Silicone Oil Cannula System - 20 Gauge
2. Silicone Oil Cannula System - 19 Gauge
3. SuperVu Galilean System
4. KOWA nonmyd 7 / VK-2 Digital Imaging System
5. KOWA nonmyd a-D / VK-2 Digital Imaging System
6. Refraction System RT-2100
7. Odyssey Phacoemulsification System
8. SIStem Phacoemulsification System
9. Precisionist Phacoemulsification System
10. Photon Laser Phacoemulsification System
11. Phaco-Emulsification System
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products:
(Date:11/21/2008)...1 Album Creative Studios, Inc., a ...program offering big brand marketing for small bus...nsive ad agency process and services, and tailored...roach," says Matt Parker, Creative Director. Alb... and proven brand-building techniques to build "Ro...
(Date:11/21/2008)...d to work together to stop abusive behavior, exper...ws) -- Behavior that was once dismissed as "kids b... as mounting research shows the negative effects o...fessionals, schools, parents and even kids themsel...eatening behavior. , "Bullying shouldn,t be co...
(Date:11/21/2008)...orida State University College of Medicine researc...rtant new layer of regulation in the cell division...g of the way cancer begins. , Wang, an assistant...f Medicine, said the findings will lead to an impr...the design of new drugs that kill cancer cells by ...
(Date:11/21/2008)...ewswire-USNewswire/ -- During a memorial service ...l today remembered Lieutenant Governor Catherine B...tner in public service, and a tireless advocate fo...irst woman elected lieutenant governor, Catherine ...rnor Rendell. "Her family and her faith were drivi...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3
...effect of the serving environment on alcohol relat...aid, "There is no reliable evidence that intervent...n reducing injury," fatal or otherwise. There were...ng, but if you’re only able to train 50 percent or...
...ood tests over skin tests for detecting people wit...ests are effective, reliable and therefore holds p...s people with the dormant TB infection never actua...e, yet it becomes imperative to detect such cases ...
...t there is an apparent increase in premature birth...tnessed in preterm deliveries between 1995 and 200...w risk women aged 20 – 40. The study had also focu... elective deliveries. All these complications also...
... has made a paradigm shift from being a generic dr...growth aggressively. // "We are rapidly transform...redients) manufacturer into an innovator for devel...molecules. "We believe this strategy will deliver...
Other Medicine News:Health News:Biocon To Shift Focus On Innovation To Accelerate Growth 2
(Date:11/20/2008)...ov. 20 GlaxoSmithKline (N...s Food and Drug Administration (FDA) granted accel...the treatment of thrombocytopenia in patients with...ura (ITP) who have had an insufficient response to...The approval is a significant milestone for PROMAC...
(Date:11/20/2008)...-FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI ) an...Phase 1B,clinical trial of their lead drug candid..., at the Society for Integrative Oncology,s Fifth ...e Company,s oral presentation was selected,as a t...t of the Best of the,SIO Session on November 20, ...
(Date:11/20/2008)...-- PAREXEL International Corporation (Nasdaq: PR...provider, today announced that it has opened an of...g and clinical research capabilities. With the add...s throughout five important biopharmaceutical cent..., Brazil, Chile, and Mexico. This expansion furthe...
(Date:11/19/2008)...stical significance , , ISELIN, N.J., Nov. ...(Nasdaq: PARS ) today announced results from its...on (NE) drug delivery technology formulated with 3...center, randomized, double-blinded, placebo-contro...e Company,s 3% Diclofenac Diethanolamine NanoEmuls...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3079 1Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3079 2Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3079 3Massive American Red Cross Tornado Relief Effort Spans Five States 11169 1Massive American Red Cross Tornado Relief Effort Spans Five States 11169 2Customer Experience Conference Feb 25 27 3A Sharing New Insights on Winning Customer Loyalty 11165 1Customer Experience Conference Feb 25 27 3A Sharing New Insights on Winning Customer Loyalty 11165 2Best Practice Database 3A Complimentary Excerpt of Three Sales Force Excellence Studies 11162 1Best Practice Database 3A Complimentary Excerpt of Three Sales Force Excellence Studies 11162 2
....--(BUSINESS WIRE)--Apr 25, 2007 - Geron,Corporati...ations,on the role of telomerase and telomeres in ...cer Research (AACR) Annual Meeting in,Los Angeles....mere,and telomerase biology reflecting the growing...omerase as a universal cancer,target for drug and ...
...--(BUSINESS WIRE)--Apr 25, 2007 - BioDelivery,Scie...today,statistically significant results with BEMA(...pain in its pivotal Phase III efficacy,clinical tr...evement of the primary efficacy endpoint of the tr...compared to placebo., The results demonstrated tha...
Other Medicine Technology:Telomerase Presentations at the AACR 2007 Annual Meeting 2Telomerase Presentations at the AACR 2007 Annual Meeting 3Telomerase Presentations at the AACR 2007 Annual Meeting 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 3BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 5BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 6